Journal of the Neurological Sciences
Volume 226, Issue 1 , Pages 41-44 , 15 November 2004

Cerebral amyloid angiopathy and gene polymorphisms

References 

  1. Vinters HV. Cerebral amyloid angiopathy: a critical review. Stroke. 1987;18::311–324
  2. Yamada M. Cerebral amyloid angiopathy: an overview. Neuropathology. 2000;20:8–22
  3. Revesz T, Ghiso J, Lashley T, Ghebremedhin E, Rüb U, Yamaguchi H, et al. Cerebral amyloid angiopathies: a pathologic, biochemical, and genetic view. J. Neuropathol. Exp. Neurol. 2003;62:885–898
  4. Sloan MA, Price TR, Petito CK, Randall AM, Solomon RE, Terrin ML, et al. Clinical features and pathogenesis of intracerebral hemorrhage after rt-PA and heparin therapy for acute myocardial infarction: the thrombolysis in myocardial infarction (TIMI) II pilot and randomized clinical trial combined experience. Neurology. 1995;45:649–658
  5. Winkler DT, Biedermann L, Tolnay M, Allegrini PR, Staufenbiel M, Wiessner C, et al. Thrombolysis induces cerebral hemorrhage in a mouse model of cerebral amyloid angiopathy. Ann. Neurol. 2002;51:790–793
  6. Pfeifer M, Boncristiano S, Bondolfi L, Stalder A, Deller T, Staufenbiel M, et al. Cerebral hemorrhage after passive anti-Aβ immunotherapy. Science. 2002;298:1379
  7. Calhoun ME, Burgermeister P, Phinney AL, Stalder M, Tolnay M, Wiederhold K-H, et al. Neuronal overexpression of mutant amyloid precursor protein results in prominent deposition of cerebrovascular amyloid. Proc. Natl. Acad. Sci. U. S. A. 1999;96:14088–14093
  8. Urmoneit B, Prikulis I, Wihl G, D'Urso D, Frank R, Heeren J, et al. Cerebrovascular smooth muscle cells internalize Alzheimer amyloid beta protein via a lipoprotein pathway: implications for cerebral amyloid angiopathy. Lab. Invest. 1997;77:157–166
  9. Weller RO, Massey A, Newman TA, Hutchings M, Kuo YM, Roher AE. Cerebral amyloid angiopathy: amyloid β accumulates in putative interstitial fluid drainage pathways in Alzheimer's disease. Am. J. Pathol. 1998;153:725–733
  10. Wyss-Coray T, Masliah E, Mallory M, McConlogue L, Johnson-Wood K, Lin C, et al. Amyloidogenic role of cytokine TGF-α1 in transgenic mice and in Alzheimer's disease. Nature. 1997;389:603–606
  11. Yamada M, Itoh Y, Shintaku M, Kawanura J, Jensson O, Thornsteinsson L, et al. Immune reactions associated with cerebral amyloid angiopathy. Stroke. 1996;27:1155–1162
  12. Greenberg SG, Rebeck GW, Vonsattel JPG, Gomez-Isla T, Hyman BT. Apolipoprotein E ɛ4 and cerebral hemorrhage associated with amyloid angiopathy. Ann. Neurol. 1995;38:254–259
  13. Premkumar DRD, Cohen DL, Hedera P, Freidland RP, Kalaria RN. Apolipoprotein E ɛ4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease. Am. J. Pathol. 1996;148:2083–2095
  14. Nicoll JAR, Burnett C, Love S, Graham DI, Dewar D, Ironside JW, et al. High frequency of apolipoprotein E ɛ2 in hemorrhage due to cerebral amyloid angiopathy. Ann. Neurol. 1997;41:716–721
  15. Itoh Y, Yamada M, Suematsu N, Matsushita M, Otomo E. Influence of apolipoprotein E genotype on cerebral amyloid angiopathy in the elderly. Stroke. 1996;27:216–218
  16. Yamada M, Itoh Y, Otomo E, Suematsu N, Matsushita M. Lack of the association between apolipoprotein E and cerebral amyloid angiopathy in the elderly Japanese. Ann. Neurol. 1996;39:683
  17. Yamada M, Sodeyama N, Itoh Y, Suematsu N, Otomo E, Matsusita M, et al. Association of presenilin-1 polymorphism with cerebral amyloid angiopathy in the elderly. Stroke. 1997;28:2219–2221
  18. Yamada M, Sodeyama N, Itoh Y, Suematsu N, Otomo E, Matsusita M, et al. Association of α1-antichymotrypsin polymorphism with cerebral amyloid angiopathy. Ann. Neurol. 1998;44:129–131
  19. Yamada M, Sodeyama N, Itoh Y, Suematsu N, Otomo E, Matsushita M, et al. Butyrylcholinesterase K variant and cerebral amyloid angiopathy. Stroke. 1998;29:2488–2490
  20. Yamada M, Sodeyama N, Itoh Y, Suematsu N, Otomo E, Matsushita M, et al. A deletion polymorphism of α2-macroglobulin gene and cerebral amyloid angiopathy. Stroke. 1999;30:2277–2279
  21. Yamada M, Sodeyama N, Itoh Y, Suematsu N, Otomo E, Matsushita M, et al. No association of paraoxonase genotype or atherosclerosis with cerebral amyloid angiopathy. Stroke. 2002;33:896–900
  22. Yamada M, Sodeyama N, Itoh Y, Takahashi A, Otomo E, Matsushita M, et al. Association of neprilysin polymorphism with cerebral amyloid angiopathy. J. Neurol. Neruosurg. Psychiatry. 2003;74:749–751
  23. Kawamata J, Tanaka S, Shimohama S, Ueda K, Kimura J. Apolipoprotein E polymorphism in Japanese patients with Alzheimer's disease or vascular dementia. J. Neurol. Neurosurg. Psychiatry. 1994;57:1414–1416
  24. Thal DR, Ghebremedhin E, Rüb U, Yamaguchi H, Tredci KD, Braak H. Two types of sporadic cerebral amyloid angiopathy. J. Neuropathol. Exp. Neurol. 2002;61:282–293
  25. Vidal R, Calero M, Piccardo P, Farlow MR, Unverzagt FW, Ménddez E, et al. Senile dementia associated with amyloid β protein angiopathy and tau perivascular pathology but not neuritic plaques in patients homozygous for the APOE-ɛ4 allele. Acta Neuropathol. 2000;100:1–12
  26. Yamada M, Itoh Y, Suematsu N, Otomo E, Matsushita M. Vascular variant of Alzheimer's disease characterized by severe plaque-like β protein angiopathy. Dement. Geriatr. Cogn. Disord. 1997;8:163–168
  27. McCarron MO, Nicoll JA, Stewart J, Ironside JW, Mann DM, Love S, et al. The apolipoprotein E epsilon2 allele and the pathological features in cerebral amyloid angiopathy-related hemorrhage. J. Neuropathol. Exp. Neurol. 1999;58:711–718
  28. O'Donnell HC, Rosand J, Knudsen KA, Furie KL, Segal AZ, Chiu RI, et al. Apolipoprotein E genotype and the risk of recurrent lobar intracerebral hemorrhage. N Engl J Med 342 240–45.
  29. Iwata N, Tsubuki S, Takaki Y, Watanabe K, Sekiguchi M, Hosoki E, et al. Identification of the major Aβ1-42-degrading catabolic pathway in brain parenchyma: suppression leads to biochemical and pathological deposition. Nature Med. 2000;6:143–150
  30. Takaki Y, Iwata N, Tsubuki S, Taniguchi S, Toyoshima S, Lu B, et al. Biochemical identification of the neutral endopeptidase family member responsible for the catabolism of amyloid β peptide in the brain. J. Biochem. 2000;128:897–902
  31. Iwata N, Tsubuki S, Takaki Y, Shirotani K, Lu B, Gerard NP, et al. Metabolic regulation of brain Aβ by neprilysin. Science. 2001;292:1550–1552
  32. Li C, Mooze RM, Hershi LB. Tissue-specific expression of rat neutral endopeptidase (neprilysin) mRNAs. J. Biol. Chem. 1995;270:5723–5728
  33. Sodeyama N, Mizusawa H, Yamada M, Itoh Y, Otomo E, Matsushita M. Lack of association of neprilysin polymorphism with AD and AD type neuropathological changes. J. Neurol. Neurosurg. Psychiatry. 2001;71:817–818
  34. Hamaguchi T, Okino S, Sodeyama N, Itoh Y, Takahashi A, Otomo E, et al. Association of a polymorphism of the transforming growth factor-β1 gene with cerebral amyloid angiopathy. J Neurol Neurosurg Psychiatry (in press).

PII: S0022-510X(04)00290-4

doi: 10.1016/j.jns.2004.09.009

Journal of the Neurological Sciences
Volume 226, Issue 1 , Pages 41-44 , 15 November 2004

Article Tools